Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. APGE
7. DFTX
8. LCO
9. KR
10. MSTR

Go back to Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia
(NASDAQ: KURA) Delayed: 10.45 +0.52 (5.24%)
Previous Close $9.93    52 Week High $8.90 
Open $9.96    52 Week Low $2.50 
Day High $10.48    P/E N/A 
Day Low $9.95    EPS $0.00 
Volume 517,427